Drugs in management of hyperkinetic and perceptually handicapped children.
D000927:Anticonvulsants / Q000627:therapeutic use*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D003913:Dextroamphetamine / Q000627:therapeutic use; D004827:Epilepsy / Q000150:complications; D006801:Humans; D006948:Hyperkinesis / Q000175:diagnosis / Q000188:drug therapy*; D008774:Methylphenidate / Q000627:therapeutic use; D010468:Perceptual Disorders / Q000188:drug therapy*; D010672:Phenytoin / Q000627:therapeutic use; D011324:Primidone / Q000627:therapeutic use; D011581:Psychological Tests; D012640:Seizures / Q000150:complications; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D000927:Anticonvulsants; D000697:Central Nervous System Stimulants; D014149:Tranquilizing Agents; D011324:Primidone; D008774:Methylphenidate; D010672:Phenytoin; D002707:Chlordiazepoxide; D003913:Dextroamphetamine; D002746:Chlorpromazine